OppenheimerFunds’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

OppenheimerFunds’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$16.9M	Hold	100,000	–	–	0.02%	575
2018 Q4	$9.74M	Hold	100,000	–	–	0.01%	666
2018 Q3	$17.3M	Hold	100,000	–	–	0.02%	620
2018 Q2	$14M	Hold	100,000	–	–	0.02%	663
2018 Q1	$11.3M	Sell	100,000 -78,430	-44%	-$9.86M	0.01%	679
2017 Q4	$23.6M	Buy	178,430 +78,430	+78%	+$9.22M	0.03%	534
2017 Q3	$10.1M	Hold	100,000	–	–	0.01%	738
2017 Q2	$10M	Hold	100,000	–	–	0.01%	740
2017 Q1	$12.1M	Hold	100,000	–	–	0.01%	730
2016 Q4	$11.2M	Hold	100,000	–	–	0.01%	738
2016 Q3	$13.3M	Hold	100,000	–	–	0.02%	678
2016 Q2	$9.16M	Hold	100,000	–	–	0.01%	735
2016 Q1	$7.21M	Hold	100,000	–	–	0.01%	766
2015 Q4	$6.94M	Sell	100,000 -1,100,000	-92%	-$89.6M	0.01%	788
2015 Q3	$9.14M	Buy	1,200,000 +1,100,000	+1,100%	+$122M	0.01%	740
2015 Q2	$12.3M	Buy	+100,000	New	+$11.3M	0.01%	707

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OppenheimerFunds's GWPH Position: Q1 2019 in Review

OppenheimerFunds held its GW Pharmaceuticals Plc American Depositary Shares (GWPH) position steady in Q1 2019 at 100,000 shares worth $16.9M. The position accounts for 0.02% of the portfolio, ranked #575.

OppenheimerFunds first reported a position in GWPH in Q2 2015 and has held it in 16 quarters since. The position peaked at $23.6M in Q4 2017. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

OppenheimerFunds held 100,000 shares of GW Pharmaceuticals Plc American Depositary Shares worth $16.9M as of Q1 2019.
OppenheimerFunds left its GW Pharmaceuticals Plc American Depositary Shares share count unchanged in Q1 2019.
GW Pharmaceuticals Plc American Depositary Shares made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #575 holding.
OppenheimerFunds first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2015 and has held it in 16 quarters since.
OppenheimerFunds's GW Pharmaceuticals Plc American Depositary Shares position peaked at $23.6M in Q4 2017.
320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.